WO2013048365A1 - Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems - Google Patents
Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems Download PDFInfo
- Publication number
- WO2013048365A1 WO2013048365A1 PCT/US2011/053284 US2011053284W WO2013048365A1 WO 2013048365 A1 WO2013048365 A1 WO 2013048365A1 US 2011053284 W US2011053284 W US 2011053284W WO 2013048365 A1 WO2013048365 A1 WO 2013048365A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- amine
- agglomerate
- hydrate inhibitor
- organic
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title claims abstract description 46
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 239000003345 natural gas Substances 0.000 title claims abstract description 7
- 239000003209 petroleum derivative Substances 0.000 title claims abstract description 6
- NMJORVOYSJLJGU-UHFFFAOYSA-N methane clathrate Chemical compound C.C.C.C.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O NMJORVOYSJLJGU-UHFFFAOYSA-N 0.000 title abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 51
- 150000001412 amines Chemical class 0.000 claims abstract description 42
- 150000004820 halides Chemical class 0.000 claims abstract description 32
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 31
- 150000007524 organic acids Chemical class 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 20
- 235000005985 organic acids Nutrition 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 10
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 6
- -1 di-n-proplyamine Chemical compound 0.000 claims description 21
- 229930195733 hydrocarbon Natural products 0.000 claims description 13
- 150000002430 hydrocarbons Chemical class 0.000 claims description 13
- 239000004215 Carbon black (E152) Substances 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 8
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- ZRUPXAZUXDFLTG-UHFFFAOYSA-N 1-aminopentan-2-ol Chemical compound CCCC(O)CN ZRUPXAZUXDFLTG-UHFFFAOYSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000005711 Benzoic acid Substances 0.000 claims description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 4
- 235000010233 benzoic acid Nutrition 0.000 claims description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- 239000003760 tallow Substances 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 3
- CFQZKFWQLAHGSL-FNTYJUCDSA-N (3e,5e,7e,9e,11e,13e,15e,17e)-18-[(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(3e,5e,7e,9e,11e,13e,15e)-octadeca-3,5,7,9,11,13,15,17-octaenoyl]oxyoctadeca-3,5,7,9,11,13,15,17-octaenoyl]oxyoctadeca-3,5,7,9,11,13,15,17-octaenoic acid Chemical compound OC(=O)C\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C=C\OC(=O)C\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C=C\OC(=O)C\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C=C CFQZKFWQLAHGSL-FNTYJUCDSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- IWSZDQRGNFLMJS-UHFFFAOYSA-N 2-(dibutylamino)ethanol Chemical compound CCCCN(CCO)CCCC IWSZDQRGNFLMJS-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- YPIFGDQKSSMYHQ-UHFFFAOYSA-N 7,7-dimethyloctanoic acid Chemical compound CC(C)(C)CCCCCC(O)=O YPIFGDQKSSMYHQ-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 claims description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
- UIERETOOQGIECD-UHFFFAOYSA-N Angelic acid Natural products CC=C(C)C(O)=O UIERETOOQGIECD-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 2
- RZKSECIXORKHQS-UHFFFAOYSA-N Heptan-3-ol Chemical compound CCCCC(O)CC RZKSECIXORKHQS-UHFFFAOYSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- AKNUHUCEWALCOI-UHFFFAOYSA-N N-ethyldiethanolamine Chemical compound OCCN(CC)CCO AKNUHUCEWALCOI-UHFFFAOYSA-N 0.000 claims description 2
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- UIERETOOQGIECD-ARJAWSKDSA-N angelic acid Chemical compound C\C=C(\C)C(O)=O UIERETOOQGIECD-ARJAWSKDSA-N 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical compound C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 claims description 2
- 229940087675 benzilic acid Drugs 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000539 dimer Substances 0.000 claims description 2
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 claims description 2
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 claims description 2
- 229940031098 ethanolamine Drugs 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- 150000002462 imidazolines Chemical class 0.000 claims description 2
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 claims description 2
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 claims description 2
- NHLUVTZJQOJKCC-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCN(C)C NHLUVTZJQOJKCC-UHFFFAOYSA-N 0.000 claims description 2
- UQKAOOAFEFCDGT-UHFFFAOYSA-N n,n-dimethyloctan-1-amine Chemical compound CCCCCCCCN(C)C UQKAOOAFEFCDGT-UHFFFAOYSA-N 0.000 claims description 2
- IKVDMBQGHZVMRN-UHFFFAOYSA-N n-methyldecan-1-amine Chemical compound CCCCCCCCCCNC IKVDMBQGHZVMRN-UHFFFAOYSA-N 0.000 claims description 2
- OMEMQVZNTDHENJ-UHFFFAOYSA-N n-methyldodecan-1-amine Chemical compound CCCCCCCCCCCCNC OMEMQVZNTDHENJ-UHFFFAOYSA-N 0.000 claims description 2
- SZEGKVHRCLBFKJ-UHFFFAOYSA-N n-methyloctadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCNC SZEGKVHRCLBFKJ-UHFFFAOYSA-N 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 150000002989 phenols Chemical class 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 239000003784 tall oil Substances 0.000 claims description 2
- RJSZFSOFYVMDIC-UHFFFAOYSA-N tert-butyl n,n-dimethylcarbamate Chemical compound CN(C)C(=O)OC(C)(C)C RJSZFSOFYVMDIC-UHFFFAOYSA-N 0.000 claims description 2
- 229940086542 triethylamine Drugs 0.000 claims description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims description 2
- 229960004418 trolamine Drugs 0.000 claims description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 claims 2
- 230000007797 corrosion Effects 0.000 abstract description 21
- 238000005260 corrosion Methods 0.000 abstract description 21
- 238000004519 manufacturing process Methods 0.000 abstract description 18
- 230000015572 biosynthetic process Effects 0.000 abstract description 10
- 238000005336 cracking Methods 0.000 abstract description 8
- 150000007513 acids Chemical class 0.000 abstract description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 239000002168 alkylating agent Substances 0.000 abstract description 2
- 229940100198 alkylating agent Drugs 0.000 abstract description 2
- 229910001504 inorganic chloride Inorganic materials 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000007789 gas Substances 0.000 description 15
- 239000013078 crystal Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 150000004677 hydrates Chemical class 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 150000001450 anions Chemical class 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- 150000003839 salts Chemical group 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 150000001805 chlorine compounds Chemical class 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 229910001502 inorganic halide Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 3
- 229940073608 benzyl chloride Drugs 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 238000006053 organic reaction Methods 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000004653 carbonic acids Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910000856 hastalloy Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 150000002835 noble gases Chemical class 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 231100000098 severe acute toxicity Toxicity 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/52—Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2208/00—Aspects relating to compositions of drilling or well treatment fluids
- C09K2208/22—Hydrates inhibition by using well treatment fluids containing inhibitors of hydrate formers
Definitions
- the systems and methods described herein pertain to the production of petroleum products and natural gas, and particularly to compositions effective as anti- agglomerate low dosage gas hydrate inhibitors ("LDHI's") for the prevention of gas hydrate plugs.
- LDHI's low dosage gas hydrate inhibitors
- Gas hydrates are solids that may form during hydrocarbon production, in particular in pipelines and other equipment, that may impede or completely block flow of hydrocarbons. These blockages not only decrease or stop production, potentially costing millions of dollars in lost production, but are also very difficult and dangerous to mediate. Unless properly handled, gas hydrates may explode, rupturing pipelines, damaging equipment, endangering workers and putting at risk the ocean environment.
- Gas hydrates may form when water molecules become bonded together after coming into contact with certain "guest" gas molecules. Hydrogen bonding causes the water molecules to form a regular lattice structure that is stabilized by the guest gas molecules. The resulting crystalline structure precipitates as a solid gas hydrate.
- Guest molecules can include any number of molecules, including carbon dioxide, methane, butane, propane, hydrogen, helium, freons, halogens, and noble gases.
- Thermodynamic, anti-agglomerate, and kinetic inhibitors are three general classes of hydrate inhibitors.
- Thermodynamic inhibitors are most commonly used.
- Thermodynamic inhibitors such as methanol and ethylene glycol must typically be used at high concentrations to be effective, concentrations that may present environmental concerns. For instance, methanol is used in concentrations of up to 50% methanol to water ratio, with glycol as much as 30% glycol to water. Methanol presents other challenges, as it is flammable and can be corrosive.
- thermodynamic inhibitors are often not appropriate for many drilling operations, particularly environmentally-sensitive drilling operations.
- Kinetic inhibitors and anti-agglomerate inhibitors typically function at lower concentrations than thermodynamic inhibitors and are therefore termed LDHI's.
- Kinetic hydrate inhibitors are polymers that may prevent or delay the nucleation of hydrates. Thus the kinetic hydrate inhibitors limit hydrate crystal size and growth such that hydrate plugs are not allowed to form in tubular goods.
- kinetic hydrate inhibitors are capable of handling only low-to moderate subcooling - typically subcooling of about 10 - 25° F (subcooling is the difference between the operating temperature of the hydrocarbon system and the temperature at which hydrates would form at the same operating pressure).
- subcooling is the difference between the operating temperature of the hydrocarbon system and the temperature at which hydrates would form at the same operating pressure.
- kinetic hydrate inhibitors may not be suitable in deep and ultra-deep wells, where subcooling may be greater than 30°F.
- Anti-agglomerate gas inhibitors are typically more cost effective than thermodynamic inhibitors, as they may be used in much lower concentrations and are typically useful in environments with greater subcooling than would be appropriate for kinetic inhibitors.
- many of the traditional anti-agglomerate LDHI's contain residual halides, such as HC1, HBr, and the like, and residual organic halides. Residual halides have been know to cause corrosion and stress corrosion cracking ("SCC") in metal piping and production equipment.
- SCC corrosion and stress corrosion cracking
- One example of a commonly used anti-agglomerate LDHI is quaternary an ti- agglomerates containing residual organic halides, such as Kelland, 2006. As an example, Milburn et al. U.S. Patent No.
- the present disclosure relates generally to the field of gas and oil production. Other uses may also be made of same. In particular, compositions and methods for inhibiting the formation of gas hydrate plugs are described.
- compositions which are an ti- agglomerate low dosage hydrate inhibitors ("AA-LDHI"s) that are made without the use of organic chlorides or halides to minimize residual organic halides other resultant inorganic halides that are respectively highly toxic and corrosive.
- AA-LDHI ti- agglomerate low dosage hydrate inhibitors
- examples of such halides include HF, HC1, HBr, HI, and the like.
- compositions are structurally similar to quaternary amines, they are reaction products of organic acids and organic amines that eliminate or substantially reduce residual inorganic or organic halides (MX), and/or residual hydrogen halides (HC1, HBr, HI, and the like).
- MX inorganic halides
- HX hydrogen halides
- Inorganic halides (MX), and/or residual HX are often created as byproducts when quaternary salts are produced using chlorinated or halogenated alkylating agents. These agents typically include benzyl chloride, bromide, iodide, or the like, of the structure R-X wherein R is any organic structure. This byproduct formation is due to their reaction with water either during or after the reaction.
- the anti-agglomerate low dosage hydrate inhibitors are mixtures of organic reaction products of organic acids and organic amines, including but not limited to those including fatty acids and fatty amines.
- compositions effectively inhibit the formation of gas hydrates in petroleum and natural gas production systems without the negative effects associated with residual chlorides or other halides, such as high corrosion rates, stress cracking, and potential high toxicity.
- Figure 1 shows a general structure of a quaternary ammonium salt having a chloride or other halide anion, wherein R 1 , R 2 , R 3 , and R 4 are generally and independently H or C 1 -C40, and X is generally F, CI, Br, I, other halides, or similar suitable substituents.
- Figure 2 shows general structures (a) and (b) of organic reaction products of organic acids and organic amines having an organic anion, wherein R 1 , R 2 , and R 3 are independently H or C 1 -C40, including all alkyl and aryl structures and isomers, and wherein R 4 is Q-C40, including all alkyl and aryl structures and isomers.
- Figure 3 shows a preferred embodiment of a general structure of the reaction product of a coconut oil based amine and a fatty coconut oil based acid, wherein n is 8-12.
- Figure 4 shows the results of a comparison of the effectiveness of four anti- agglomerate compositions based on rating criteria.
- the current anti-agglomerate compositions include mixtures of reaction products of non-halide-containing inorganic acids and/or organic acids with organic amines.
- the reaction products are structurally similar to other quaternary amine halide analogs, but the reaction products lack acid halides, inorganic halides, and organic halides.
- Certain embodiments include mixtures of reaction products of organic acids and organic amines, including an anti- agglomerate low dosage hydrate inhibitor that is free of acid halides, inorganic halides, and organic halides and that can be injected continuously with minimized concern for corrosion, stress corrosion cracking, or highly toxic reactants or reaction products.
- FIG. 1 shows a traditional example of a quaternary ammonium salt utilizing a halide as an anion.
- the quaternary ammonium cation is that portion of the molecule that has a positive charge, NRiR 2 R3R4 + .
- the term quaternary amine is often used to refer to the positively charged quaternary ammonium compound.
- R l5 R2, R 3 , and R4 can be any number of suitable constituents, including hydrogen (H), methyl (CH 3 ), ethyl (CH 2 CH 3 ), acetyl (COCH 3 ), other alkyl or aryl groups of varying lengths and structures, and others. Some of the R constituents may also be connected to each other. Those of skill in the art with the benefit of this disclosure will understand the varying natures of the R constituents.
- the anti-agglomerate LDHI is the reaction products of organic acid and organic amines.
- Reaction products of organic acids and organic amines are formed when certain organic acids are partially neutralized, giving them at least a partial negative charge that enables them to serve as anions in a salt.
- Figure 2 shows some general examples of reaction products or organic acids and organic amines having the structure R 1 R 2 R 3 HN + (R 4 COO " ) or R 1 R 2 R 3 HN + (R 4 PhO " ), wherein R 1 , R 2 , and R 3 are independently H or C1-C40, wherein R 4 is Q-C40, and wherein Ph is any phenyl group.
- the substituents C1-C4 0 include all alkyl and aryl structures and isomers within these embodiments.
- the negatively charged anions are anions created by partial or complete neutralization of acids.
- Certain embodiments can include reactions or mixtures that include varying ratios of the organic acid, organic amine, and the resulting salt of the reaction of the organic acid and amine.
- approximately stoichiometric amounts of the organic acid and amine are used to create the resultant salt.
- molar ratios of the reactants are adjusted so as to create a surplus of free organic amine in the resultant reaction product.
- the excess amine is less than about 1% (by mol) of the reaction product.
- the compounds that can be used as cations with the desired acid anions can be any suitable non-halide-containing amines.
- Ri, R 2 , and R 3 can be any suitable substituents, including hydrogen (H), methyl (CH 3 ), ethyl (CH 2 CH 3 ), acetyl (COCH 3 ), and other alkyl or aryl groups of varying lengths.
- Some of the R substituents may also be connected to each other and can include oxygen, nitrogen, and the like.
- Suitable cations include, but are not limited to ammonia, methylamine, di methylamine, tri methylamine, ethylamine, di ethylamine, tri ethylamine, n- propylamine, di-n-proplyamine, tri-n-propylamine, monoethanolamine, di ethanolamine, diethyl ethanaol amine, methyl ethanol amine, tri ethanol amine, methyl diethanol amine, propyl ethanolamine, ethyl diethanol amine, di methyl amino propyl amine, di propyl ethanol amine, din-butyl amine, di butyl propanol amine, dibutyl ethanolamine, morpholine, piperazine, octyl amine, dimethyl octyl amine, decyl amine, di methyl decyl amine, lauryl amine, dimethyl laurylamine, myristyl amine, dimethyl palmity
- R4 can be any suitable constituents, including hydrogen (H), methyl (CH 3 ), ethyl (CH 2 CH 3 ), acetyl (COCH 3 ), and other alkyl or aryl groups of varying lengths, and can include oxygen, nitrogen, and the like.
- Suitable anions include formic acid, acetic acid, lactic acid, cyanuric acid, angelic acid, propionic acid, butyric acid, aspartic acid, glycolic acid, adipic acid, maleic acid, citric acid, phthalic acid, anthranilic acid, octanoic acid, lauric acid, benzoic acid, salicylic acid, fumaric acid, oxalic acid, succinic acid, acrylic acid, cinnamic acid, azelaic acid, neodecanoic acid, benzilic acid, pelargonic acid, stearic acid, dimer acid, trimer acid, varying ratios of dimer-trimer acid blends, methane sulfonic acid, dodecyl benzene sulfonic acid, para- tolunene sulfonic acid, oleic acid, tall oil fatty acid, linoleic acid, abietic acid, rosin acid, napthe
- Examples of salts that meet one or more criteria above include the reaction product of a 1:1 molar ratio of benzoic acid and dimethyl palmitoyl amine, a 2:1 molar ratio of phthalic anhydride and cocodiamine, and a 2: 1 molar ratio of salicylic acid and cocodiamine.
- reaction products of organic acids and organic amines derived from coconut oil have the structure [CH3(CH2)n(CH 3 )2HN+] [CH3(CH 2 )nCOO-].
- Figure 3 shows a general representation of these possible reaction products of a coconut oil based amine and acid in which n can be varied from, for example, 8 to 12. This is an exemplary embodiment that in no way limits the scope of the anti-agglomerate compositions overall.
- Reaction products of organic acids and organic amines are more advantageous than traditional AA-LDHIs made from alkyl or aryl halides in several respects.
- AA-LDHIs In the reaction or manufacturing processes to form quaternary ammonium halides for use as AA-LDHIs it is common to form hydrogen halides and organic alcohols due to residual water present during and left over in the reaction mixtures.
- the reactants and reaction products in the current AA-LDHI compositions are not as corrosive as the likes of HC1 or HX, do not cause halide stress cracking, and are not as toxic. Because of these advantages, the anti-agglomerate compositions can be injected continuously into petroleum and natural gas systems. Methods of continuous injection include via umbilical or cap string.
- anti-agglomerate compositions can be applied at a concentration of about 0.05% to about 10%, and preferably at about 0.2% to about 1.5%.
- anti-agglomerate compositions comprised of mixtures of reaction products of organic acids and organic amines work by helping to emulsify water in oil. It is generally agreed that anti-agglomerate LDHI molecules need hydrocarbon to function and tend to emulsify water as an internal emulsion phase. This limits the growth and size of hydrate crystals to a form and size that does not allow the hydrates formed to plug production equipment.
- the current anti-agglomerate compositions have distinct advantages over those an ti- agglomerate compositions already commercially available, as all of these compositions contain residual chlorides.
- One advantage is the difference in corrosivity, which stems from the basic differences in corrosivity between inorganic acids such as HX or HCl and that of organic acids.
- the pKa associated with HX is much less than that associated with COOH.
- the current AA-LDHIs potentially resolve long term corrosion issues present with chlorides or HCl that are formed or are inherent in the quat type products typically used where continuous anti-agglomerate injection is required.
- Chloride stress corrosion cracking or hydrogen penetration is accelerated by the trace HCl formed in the reaction of R-Cl/R-X in quat manufacturing that has proven to be an issue in continuous versus batch use of quat based AA- LDHI.
- Testing has shown that the current anti-agglomerate compositions are equal to if not superior to the industry standard in performance.
- the current, non-quat anti- agglomerate compositions have greater oil solubility for reduction of water quality issues. This leads to increased "greenness" or environmental compatibility by partitioning more to the oil phase.
- compositions also lack certain inherent chronic or carcinogenic toxicity characteristics associated with residual RC1, RX, and other organic chloride or halide found in traditional AA-LDHIs, including vinyl chloride, benzyl chloride, alkyl bromides, and the like.
- AA-LDHIs made in accordance with the present disclosure have better stability at higher temperatures than traditional AA-LDHIs. In certain applications, it may be necessary for the AA-LDHI to be subjected to temperatures in excess of 250°F. Certain traditional AA-LDHIs, such as those made from quatenary amines, are known to degrade at higher temperatures, resulting in a reduction of efficiency in controlling hydrates. Those AA- LDHIs made in accordance with the present disclosure retain efficacy after exposure to temperatures in excess of 250°F.
- AA-LDHs made in accordance with the present disclosure, function as corrosion inhibitors. Corrosion in the production from oil and gas often is often as a result of the presence of water in the production equipment, either produced from the formation, from condensation, or from water injected into the well, for instance, for lift assist. Hydrogen sulfide (H 2 S) and carbon dioxide (C0 2 ) are often present in produced fluids, which can, in the presence of water, form acids such as sulfuric and carbonic acids (respectively). Oxygen, when present, may also contribute to corrosivity and is sometimes a contaminant in the water used for injection.
- H 2 S Hydrogen sulfide
- C0 2 carbon dioxide
- Oxygen when present, may also contribute to corrosivity and is sometimes a contaminant in the water used for injection.
- the AA-LDHIs of the present disclosure may, in addition to serving as AA- LDHIs, may function as corrosion inhibitors by contacting and coating the exposed metal of the oil and gas production equipment and piping.
- the exposed metal after being coated, by the corrosion inhibitor, prevents subsequent corrosion of the surface by the corrosive agents in the hydrocarbon stream.
- Corrosion inhibitors are normally delivered to through an umbilical to the oil and gas production equipment and piping.
- the additional use of the AA-LDHIs of the present disclosure as corrosion inhibitors has the benefit of both reducing costs to the driller by eliminating an additional on-site chemical, but also by eliminating the umbilical used to deliver the traditional corrosion inhibitor.
- AA-LDHIs made in accordance with the present disclosure were tested and compared to determine their effectiveness to prevent formation of hydrate crystals in gas production systems.
- the four AA-LDHIs tested were benzoic acid/dimethyl palmitoyl amine mixed in a 1:1 molar ratio, maleic anhydride/dimethyl palmitoyl amine mixed in a 1:1 molar ratio, methanesulfonic acid cocodiamine mixed in a 2:1 molar ratio, phthalic anhydride/cocodiamine mixed in a 2:1 molar ratio, and salicylic acid/cocodiamine mixed in a 2:1 molar ratio.
- a rocking cell test was performed on each of the four AA-LDHIs.
- the AA-LDHIs were tested in a bank of high pressure rocking cells. Each cell is outfitted with clear sapphire tubes housed and sealed in a Hastelloy body. The sapphire tubes allow for visual observation of the pressurized, cooled fluids inside the cell.
- the cells were isolated from each other and were equipped with pressure transducers and proximity sensors. A magnetic ball provided agitation as the cells are rocked back and forth at a predetermined angle and rate. The cells were submerged in a temperature controlled bath consisting of glycol and water.
- the gas composition was similar to GOM Green Canyon, a structure II hydrate former: Table 2.
- Type II Gas Composition
- Tests were all conducted at constant volume. Inhibitor concentration varied from 1-5 vol-% based upon the total amount of water.
- the cells were initially pressurized at 20°C to 2200 psig. Rocking was initialized at 15 rocks/min and an angle of +25° off horizontal. At constant temperature of 20°C the cells were rocked for 2 hours to mix the fluids and allow for the gas to saturate the fluids. The temperature was then ramped down continuously to 4°C over a period of 2 hours while rocking.
- Ball is free but resists rolling, moderate to little change in liquid level, large solid crystals, agglomerations that break up with agitation, no visible deposits on tube
- Ball is free, no change in liquid level, viscous liquid, small dispersible agglomerations or crystals, no visible deposits on tube.
- Ball is free, no change in liquid level, little to no change in viscosity, no visible deposits on tube or cylinder, extremely fine easily dispersible crystals.
- Figure 4 shows the results of the performance ranking.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112013021905A BR112013021905A2 (en) | 2011-09-26 | 2011-09-26 | hydrate anti-caking inhibitor composition, and method for applying an anti-caking hydrate inhibiting composition to a hydrocarbon stream |
CA2827471A CA2827471C (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems |
PCT/US2011/053284 WO2013048365A1 (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems |
MX2013009634A MX2013009634A (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems. |
EP11873453.2A EP2760965A4 (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems |
AU2011378265A AU2011378265A1 (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/053284 WO2013048365A1 (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013048365A1 true WO2013048365A1 (en) | 2013-04-04 |
Family
ID=47996113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/053284 WO2013048365A1 (en) | 2011-09-26 | 2011-09-26 | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2760965A4 (en) |
AU (1) | AU2011378265A1 (en) |
BR (1) | BR112013021905A2 (en) |
CA (1) | CA2827471C (en) |
MX (1) | MX2013009634A (en) |
WO (1) | WO2013048365A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016070044A1 (en) * | 2014-10-30 | 2016-05-06 | Preferred Technology, Llc | Proppants and methods of use thereof |
US9410073B2 (en) | 2013-11-26 | 2016-08-09 | Ecolab Usa Inc. | Anti-agglomerants for controlling gas hydrates |
US9518214B2 (en) | 2013-03-15 | 2016-12-13 | Preferred Technology, Llc | Proppant with polyurea-type coating |
US9562187B2 (en) | 2012-01-23 | 2017-02-07 | Preferred Technology, Llc | Manufacture of polymer coated proppants |
US9624421B2 (en) | 2011-09-02 | 2017-04-18 | Preferred Technology, Llc | Dual function proppants |
US9725645B2 (en) | 2011-05-03 | 2017-08-08 | Preferred Technology, Llc | Proppant with composite coating |
US9790422B2 (en) | 2014-04-30 | 2017-10-17 | Preferred Technology, Llc | Proppant mixtures |
US9862881B2 (en) | 2015-05-13 | 2018-01-09 | Preferred Technology, Llc | Hydrophobic coating of particulates for enhanced well productivity |
US10006128B2 (en) | 2012-09-28 | 2018-06-26 | Ecolab Usa Inc. | Quaternary and cationic ammonium surfactants as corrosion inhibitors |
US10100247B2 (en) | 2013-05-17 | 2018-10-16 | Preferred Technology, Llc | Proppant with enhanced interparticle bonding |
US10544358B2 (en) | 2011-05-03 | 2020-01-28 | Preferred Technology, Llc | Coated and cured proppants |
US10590337B2 (en) | 2015-05-13 | 2020-03-17 | Preferred Technology, Llc | High performance proppants |
US10696896B2 (en) | 2016-11-28 | 2020-06-30 | Prefferred Technology, Llc | Durable coatings and uses thereof |
WO2020161407A1 (en) | 2019-02-06 | 2020-08-13 | Arkema France | Composition for preventing agglomeration of gas hydrates |
WO2020239338A1 (en) | 2019-05-28 | 2020-12-03 | Clariant International Ltd | Method for inhibiting gas hydrate blockage in oil and gas pipelines |
WO2020239339A1 (en) | 2019-05-28 | 2020-12-03 | Clariant International Ltd | Method for inhibiting gas hydrate blockage in oil and gas pipelines |
US11208591B2 (en) | 2016-11-16 | 2021-12-28 | Preferred Technology, Llc | Hydrophobic coating of particulates for enhanced well productivity |
US12330186B2 (en) | 2017-11-02 | 2025-06-17 | Preferred Technology, Llc | Continuous mixers and methods of using the same |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL404535A1 (en) * | 2010-09-21 | 2014-03-17 | Multi-Chem Group, Llc | Removal of water from the LDHI antiagglomeration |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566309B1 (en) * | 1999-05-03 | 2003-05-20 | Clariant Gmbh | Additives for inhibiting gas hydrate formation |
US20050261529A1 (en) * | 2004-05-18 | 2005-11-24 | Baker Hughes Incorporated | Enhancement modifiers for gas hydrate inhibitors |
US20080064611A1 (en) * | 2004-11-04 | 2008-03-13 | Spratt Paul A | Ion pair amphiphiles as hydrate inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596911B2 (en) * | 2000-02-22 | 2003-07-22 | Baker Hughes Incorporation | Composition and method for inhibition of formation of gas hydrates |
WO2004111161A1 (en) * | 2003-06-06 | 2004-12-23 | Akzo Nobel N.V. | Gas hydrate inhibitors |
CN101405364B (en) * | 2006-03-21 | 2014-04-30 | 阿克佐诺贝尔股份有限公司 | Additive for preserving the fluidity of fluids containing gas hydrates |
-
2011
- 2011-09-26 WO PCT/US2011/053284 patent/WO2013048365A1/en active Application Filing
- 2011-09-26 AU AU2011378265A patent/AU2011378265A1/en not_active Abandoned
- 2011-09-26 MX MX2013009634A patent/MX2013009634A/en not_active Application Discontinuation
- 2011-09-26 BR BR112013021905A patent/BR112013021905A2/en not_active Application Discontinuation
- 2011-09-26 EP EP11873453.2A patent/EP2760965A4/en not_active Withdrawn
- 2011-09-26 CA CA2827471A patent/CA2827471C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566309B1 (en) * | 1999-05-03 | 2003-05-20 | Clariant Gmbh | Additives for inhibiting gas hydrate formation |
US20050261529A1 (en) * | 2004-05-18 | 2005-11-24 | Baker Hughes Incorporated | Enhancement modifiers for gas hydrate inhibitors |
US20080064611A1 (en) * | 2004-11-04 | 2008-03-13 | Spratt Paul A | Ion pair amphiphiles as hydrate inhibitors |
Non-Patent Citations (1)
Title |
---|
See also references of EP2760965A4 * |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9725645B2 (en) | 2011-05-03 | 2017-08-08 | Preferred Technology, Llc | Proppant with composite coating |
US10544358B2 (en) | 2011-05-03 | 2020-01-28 | Preferred Technology, Llc | Coated and cured proppants |
US9624421B2 (en) | 2011-09-02 | 2017-04-18 | Preferred Technology, Llc | Dual function proppants |
US10087360B2 (en) | 2011-09-02 | 2018-10-02 | Preferred Technology, Llc | Dual function proppants |
US9562187B2 (en) | 2012-01-23 | 2017-02-07 | Preferred Technology, Llc | Manufacture of polymer coated proppants |
US10006128B2 (en) | 2012-09-28 | 2018-06-26 | Ecolab Usa Inc. | Quaternary and cationic ammonium surfactants as corrosion inhibitors |
US9518214B2 (en) | 2013-03-15 | 2016-12-13 | Preferred Technology, Llc | Proppant with polyurea-type coating |
US10208242B2 (en) | 2013-03-15 | 2019-02-19 | Preferred Technology, Llc | Proppant with polyurea-type coating |
US11760924B2 (en) | 2013-05-17 | 2023-09-19 | Preferred Technology, Llc | Proppant with enhanced interparticle bonding |
US11098242B2 (en) | 2013-05-17 | 2021-08-24 | Preferred Technology, Llc | Proppant with enhanced interparticle bonding |
US10100247B2 (en) | 2013-05-17 | 2018-10-16 | Preferred Technology, Llc | Proppant with enhanced interparticle bonding |
US9410073B2 (en) | 2013-11-26 | 2016-08-09 | Ecolab Usa Inc. | Anti-agglomerants for controlling gas hydrates |
US10281086B2 (en) | 2013-11-26 | 2019-05-07 | Ecolab Usa Inc. | Anti-agglomerants for controlling gas hydrates |
US9790422B2 (en) | 2014-04-30 | 2017-10-17 | Preferred Technology, Llc | Proppant mixtures |
WO2016070044A1 (en) * | 2014-10-30 | 2016-05-06 | Preferred Technology, Llc | Proppants and methods of use thereof |
US10590337B2 (en) | 2015-05-13 | 2020-03-17 | Preferred Technology, Llc | High performance proppants |
US9862881B2 (en) | 2015-05-13 | 2018-01-09 | Preferred Technology, Llc | Hydrophobic coating of particulates for enhanced well productivity |
US11208591B2 (en) | 2016-11-16 | 2021-12-28 | Preferred Technology, Llc | Hydrophobic coating of particulates for enhanced well productivity |
US10696896B2 (en) | 2016-11-28 | 2020-06-30 | Prefferred Technology, Llc | Durable coatings and uses thereof |
US12330186B2 (en) | 2017-11-02 | 2025-06-17 | Preferred Technology, Llc | Continuous mixers and methods of using the same |
WO2020161407A1 (en) | 2019-02-06 | 2020-08-13 | Arkema France | Composition for preventing agglomeration of gas hydrates |
WO2020239338A1 (en) | 2019-05-28 | 2020-12-03 | Clariant International Ltd | Method for inhibiting gas hydrate blockage in oil and gas pipelines |
WO2020239339A1 (en) | 2019-05-28 | 2020-12-03 | Clariant International Ltd | Method for inhibiting gas hydrate blockage in oil and gas pipelines |
US11753577B2 (en) | 2019-05-28 | 2023-09-12 | Clariant International Ltd. | Method for inhibiting gas hydrate blockage in oil and gas pipelines |
US11753576B2 (en) | 2019-05-28 | 2023-09-12 | Clariant International Ltd. | Method for inhibiting gas hydrate blockage in oil and gas pipelines |
Also Published As
Publication number | Publication date |
---|---|
EP2760965A4 (en) | 2015-04-22 |
CA2827471C (en) | 2016-11-01 |
CA2827471A1 (en) | 2013-04-04 |
AU2011378265A1 (en) | 2013-08-15 |
EP2760965A1 (en) | 2014-08-06 |
BR112013021905A2 (en) | 2016-11-01 |
MX2013009634A (en) | 2014-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2827471C (en) | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems | |
US9193671B2 (en) | Anti-agglomerate gas hydrate inhibitors for use in petroleum and natural gas systems | |
US6025302A (en) | Quaternized polyether amines as gas hydrate inhibitors | |
US11130902B2 (en) | Gas hydrate inhibitors | |
US11130901B2 (en) | Gas hydrate inhibitors | |
US10364385B2 (en) | Multi-tail hydrate inhibitors | |
US10745634B2 (en) | Gas hydrate inhibitors | |
US20120279715A1 (en) | Novel quaternary foamers for downhole injection | |
US8404895B2 (en) | Tertiary amine salt additives for hydrate control | |
US20160230077A1 (en) | Gas hydrate inhibitors | |
US20160362598A1 (en) | Decreasing corrosion on metal surfaces | |
US9902893B2 (en) | Multiple hydrophilic head hydrate inhibitors | |
US10550304B2 (en) | Quaternary ammonium compounds and gas hydrate inhibitor compositions | |
WO2004111161A1 (en) | Gas hydrate inhibitors | |
US11236261B2 (en) | Polyaromatic hydrocarbon additives for hydrate inhibition | |
CA3129638C (en) | Low-dosage hydrate inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11873453 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2827471 Country of ref document: CA Ref document number: 2011378265 Country of ref document: AU Date of ref document: 20110926 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2013/009634 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011873453 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013021905 Country of ref document: BR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 112013021905 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130827 |